Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
122.4 SEK | -1.61% |
|
-4.97% | -32.93% |
07-01 | Surgical Science Sweden AB Appoints Tom Englund as New CEO, Effective October 1, 2024 | CI |
05-15 | Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.93% | 595M | |
+34.98% | 9.09B | |
+33.03% | 4.4B | |
-40.24% | 2.26B | |
-9.44% | 1.6B | |
-28.89% | 1.23B | |
-43.59% | 966M | |
-10.86% | 798M | |
-49.77% | 699M | |
0.00% | 580M |
- Stock Market
- Equities
- SUS Stock
- News Surgical Science Sweden AB
- Transcript : Surgical Science Sweden AB, 2023 Earnings Call, Feb 21, 2024